Aquaculture ETF Penghua(159867) rises over 1.4%, veterinary drug raw material prices index increased by 2.3% month-on-month in February

On the news front, according to the China Veterinary Drug & Feed Trading Center, as of late March, the price index for veterinary drug raw materials was 67.57, up 2.3% month-on-month from February, and up 1.8% year-on-year compared with the same period last year.

In broker research, Huachuang Securities pointed out that, from a cause analysis perspective, the upward movement in raw material drug prices after the holiday was mainly due to sentiment transmission resulting from higher oil prices under geopolitical conflicts. Among them, doxycycline hydrochloride has strong support from sustained tight supply, and its price has continued to rebound. Florfenicol also shows a fairly clear bottom rebound trend under the dual drivers of cost increases and manufacturers holding firm on their pricing. However, products such as macrolides have remained steady. In the near to medium term, upstream and downstream players have gradually adapted to the current pace, and procurement is becoming more cautious; but if oil prices remain at high levels for the long term, it will push up prices for basic chemical raw materials, agricultural products, and logistics costs. Under cost pressure, it may also prompt manufacturers to proactively raise their quotes to pass on the cost burden.

As of 13:59 on April 2, 2026, the CSI Livestock Breeding Index (930707) surged by 1.40%. Component stocks: Jixing Agriculture and Animal Husbandry rose 10.01%, China Mufei Co., Ltd. rose 7.26%, Huisheng Bio rose 5.68%, and stocks such as Shennong Group and Haid Group followed with gains. The Penghua Livestock Breeding ETF (159867) rose 1.47%, with the latest price at 0.62 yuan.

The Penghua Livestock Breeding ETF closely tracks the CSI Livestock Breeding Index. The component stock allocation to the “Swin third-level animal health industry” is 10.64%. The CSI Livestock Breeding Index selects securities of listed companies involved in businesses such as livestock and poultry feed, livestock and poultry drugs, and livestock and poultry breeding as samples, in order to reflect the overall performance of related listed companies.

Data show that, as of March 31, 2026, the top ten weight stocks of the CSI Livestock Breeding Index (930707) were, respectively, Wen’s Co., Ltd., Haid Group, Muyuan Co., Ltd., Zhengbang Technology, Meihua Biological, New Hope, Biogen Stock, Beidahuang, Shengnong Development, and Lihua Co., Ltd., and the combined weight of the top ten accounted for 67.68%.